Invention Grant
- Patent Title: Composition 064
- Patent Title (中): 作文064
-
Application No.: US12249157Application Date: 2008-10-10
-
Publication No.: US08168221B2Publication Date: 2012-05-01
- Inventor: John David Blyth , Andrew John Day , Kieran James Lennon
- Applicant: John David Blyth , Andrew John Day , Kieran James Lennon
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Main IPC: A61K9/20
- IPC: A61K9/20
Abstract:
A pharmaceutical composition which comprises N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide with mannitol and/or 5 microcrystalline cellulose is described.
Public/Granted literature
- US20090099203A1 COMPOSITION 064 Public/Granted day:2009-04-16
Information query
